Lieber Jonathan I Insider Trades

Insider Trading History

Track insider trading activity for Lieber Jonathan I. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rallybio
Rallybio RLYB
Chief Financial Officer
Holding Value $64.6k 4,115 shares
Last Trade
Feb 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.99k 789 shares
$5.06
$15.70
Rallybio
Rallybio RLYB
Chief Financial Officer
Holding Value $77k 4,904 shares
Last Trade
Feb 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.3k 2,500 shares
$4.52
$15.70
Rallybio
Rallybio RLYB
Chief Financial Officer
Holding Value $2.83M 180,000 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$137k 180,000 shares
$0.76
$15.70
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
Director
Holding Value $17.2k 20,500 shares
Last Trade
Feb 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.39M 20,500 shares
$67.80
$0.84
Rallybio
Rallybio RLYB
Chief Financial Officer
Holding Value $1.88M 120,000 shares
Last Trade
Feb 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$223k 120,000 shares
$1.86
$15.70
Rallybio
Rallybio RLYB
Holding Value $78.5k 5,000 shares
Last Trade
Mar 14, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.1k 5,000 shares
$5.21
$15.70
Rallybio
Rallybio RLYB
See Remarks
Holding Value $3.77M 240,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.63M 240,000 shares
$6.81
$15.70
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
Director
Holding Value $2.47k 2,940 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.26k 1,440 shares
$1.57
$0.84
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Nov 30, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$60.9k 154,700 shares
$0.39
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Chief Financial Officer
Holding Value $60.9k 154,700 shares
Last Trade
Aug 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.1k 154,700 shares
$0.40
$0.39
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
Director
Holding Value $31.5k 37,500 shares
Last Trade
Jun 07, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$175k 37,500 shares
$4.66
$0.84
Salarius Pharmaceuticals
Salarius Pharmaceuticals SLRX
Director
Holding Value $25.2k 30,000 shares
Last Trade
Jan 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$360k 30,000 shares
$12.00
$0.84
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Chief Financial Officer
Holding Value $79.5k 202,000 shares
Last Trade
Sep 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$667k 202,000 shares
$3.30
$0.39
Ocugen
Ocugen OCGN
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Oct 01, 2018 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$135k 238,000 shares
$0.57
$1.38
Ocugen
Ocugen OCGN
Chief Financial Officer
Holding Value $179k 130,000 shares
Last Trade
Oct 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$181k 318,000 shares
$0.57
$1.38
Ocugen
Ocugen OCGN
Chief Financial Officer
Holding Value $179k 130,000 shares
Last Trade
Feb 16, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$342k 130,000 shares
$2.63
$1.38
Ocugen
Ocugen OCGN
Chief Financial Officer
Holding Value $69k 50,000 shares
Last Trade
Feb 14, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86k 50,000 shares
$1.72
$1.38
Ocugen
Ocugen OCGN
Chief Financial Officer
Holding Value $6.9k 5,000 shares
Last Trade
Dec 02, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.75k 5,000 shares
$1.95
$1.38
Ocugen
Ocugen OCGN
Chief Financial Officer
Holding Value $38.6k 28,000 shares
Last Trade
Feb 26, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.7k 28,000 shares
$2.56
$1.38
Ocugen
Ocugen OCGN
Chief Financial Officer
Holding Value $152k 110,000 shares
Last Trade
Jul 02, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$895k 140,000 shares
$6.39
$1.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up